Actinogen Medical Ltd
F:3AC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Actinogen Medical Ltd
F:3AC
|
AU |
|
E
|
Envestnet Inc
F:30E
|
US |
|
Ceridian HCM Holding Inc
TSX:DAY
|
US |
|
O
|
Old National Bancorp
F:ON1
|
US |
|
Earths Energy Ltd
F:3290
|
AU |
|
T
|
Tosoh Corp
XBER:TOS
|
JP |
|
C
|
Ceridian HCM Holding Inc
F:CQL
|
US |
|
B
|
Bodycote PLC
F:21T
|
UK |
|
C
|
Charbone Hydrogen Corp
OTC:CHHYF
|
CA |
|
B
|
Banxa Holdings Inc
F:AC00
|
CA |
|
Enzo Biochem Inc
OTC:ENZB
|
US |
|
G
|
GPT Group
SWB:46T
|
AU |
|
Utah Medical Products Inc
F:UTM
|
US |
|
Power Metal Resources PLC
F:2M50
|
UK |
|
Evs Broadcast Equipment SA
F:5E1
|
BE |
|
V
|
Volution Group PLC
F:VO1
|
UK |
|
Lexibook Linguistic Electronic System SA
F:LXB
|
FR |
|
C
|
China Dili Group
OTC:RNHEF
|
CN |
|
C
|
CIE Automotive SA
XMUN:CAD
|
ES |
|
I
|
Internet Initiative Japan Inc
F:I6I
|
JP |
Bankruptcy Probability
Actinogen Medical Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Actinogen Medical Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Actinogen Medical Ltd
ASX:ACW
|
159.9m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Actinogen Medical Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Actinogen Medical Ltd has total debt of 142.4k AUD. This includes both short-term (0 AUD) and long-term (142.4k AUD) debt.
You can find a full breakdown on its Balance Sheet.
